These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 18829523)
21. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Jacquemart IC; Springs AE; Chen WY Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488 [TBL] [Abstract][Full Text] [Related]
22. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Zinser GM; Welsh J Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467 [TBL] [Abstract][Full Text] [Related]
23. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747 [TBL] [Abstract][Full Text] [Related]
24. Mammary cancer stages in BALB/cV mice: mouse mammary tumor virus expression and virus-host interactions. Slagle BL; Medina D; Butel JS J Natl Cancer Inst; 1987 Aug; 79(2):323-35. PubMed ID: 3037152 [TBL] [Abstract][Full Text] [Related]
25. Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression. Kaenel P; Schwab C; Mülchi K; Wotzkow C; Andres AC Int J Oncol; 2011 Jan; 38(1):151-60. PubMed ID: 21109936 [TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861 [TBL] [Abstract][Full Text] [Related]
28. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637 [TBL] [Abstract][Full Text] [Related]
29. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875 [TBL] [Abstract][Full Text] [Related]
30. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Callahan R; Smith GH Oncogene; 2000 Feb; 19(8):992-1001. PubMed ID: 10713682 [TBL] [Abstract][Full Text] [Related]
31. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Schroeder JA; Troyer KL; Lee DC Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574 [TBL] [Abstract][Full Text] [Related]
32. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107 [TBL] [Abstract][Full Text] [Related]
33. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis. Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710 [TBL] [Abstract][Full Text] [Related]
36. Proteotypic classification of spontaneous and transgenic mammary neoplasms. Mikaelian I; Blades N; Churchill GA; Fancher K; Knowles BB; Eppig JT; Sundberg JP Breast Cancer Res; 2004; 6(6):R668-79. PubMed ID: 15535849 [TBL] [Abstract][Full Text] [Related]
37. Cancer stem cell characteristics in retinoblastoma. Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903 [TBL] [Abstract][Full Text] [Related]
38. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967 [TBL] [Abstract][Full Text] [Related]
39. Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models. Zhu P; Davis M; Blackwelder AJ; Bachman N; Liu B; Edgerton S; Williams LL; Thor AD; Yang X Cancer Prev Res (Phila); 2014 Feb; 7(2):199-210. PubMed ID: 24322659 [TBL] [Abstract][Full Text] [Related]
40. Delineating the epithelial hierarchy in the mouse mammary gland. Asselin-Labat ML; Vaillant F; Shackleton M; Bouras T; Lindeman GJ; Visvader JE Cold Spring Harb Symp Quant Biol; 2008; 73():469-78. PubMed ID: 19022771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]